title: Antihypertensive effects of inducible nitric oxide synthase inhibition in experimental pre-eclampsia.
abstract: Upregulation of inducible nitric oxide synthase (iNOS) has been reported in both experimental and clinical hypertension. However, although pro-inflammatory cytokines that up-regulate iNOS contribute to pre-eclampsia, no previous study has tested the hypothesis that a selective iNOS inhibitor (1400 W) could exert antihypertensive effects associated with decreased iNOS expression and nitrosative stress in pre-eclampsia. This study examined the effects of 1400 W in the reduced uteroplacental perfusion pressure (RUPP) placental ischaemia animal model and in normal pregnant rats. Sham-operated and RUPP rats were treated with daily vehicle or 1 mg/kg/day N-[3-(Aminomethyl) benzyl] acetamidine (1400 W) subcutaneously for 5 days. Plasma 8-isoprostane levels, aortic reactive oxygen species (ROS) levels and nicotinamide adenine dinucleotide phosphate (NADPH)-dependent ROS production were evaluated by ELISA, dihydroethidium fluorescence microscopy and lucigenin chemiluminescence respectively. Inducible nitric oxide synthase expression was assessed by western blotting analysis and aortic nitrotyrosine was evaluated by immunohistochemistry. Mean arterial blood pressure increased by ~30 mmHg in RUPP rats, and 1400 W attenuated this increase by ~50% (P < 0.05). While RUPP increased plasma 8-isoprostane levels, aortic ROS levels, and NADPH-dependent ROS production (P < 0.05), treatment with 1400 W blunted these alterations (P < 0.05). Moreover, while RUPP increased iNOS expression and aortic nitrotyrosine levels (P < 0.05), treatment with 1400 W blunted these alterations (P < 0.05). These results clearly implicate iNOS in the hypertension associated with RUPP. Our findings may suggest that iNOS inhibitors could be clinically useful in the therapy of pre-eclampsia, especially in particular groups of patients genetically more prone to express higher levels of iNOS. This issue deserves further confirmation.
authors.affiliation: Department of Pharmacology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, SP, Brazil.
authors.forename: Lorena M
authors.initials: LM
authors.lastname: Amaral
authors.forename: Lucas C
authors.initials: LC
authors.lastname: Pinheiro
authors.forename: Danielle A
authors.initials: DA
authors.lastname: Guimaraes
authors.forename: Ana C T
authors.initials: AC
authors.lastname: Palei
authors.forename: Jonas T
authors.initials: JT
authors.lastname: Sertório
authors.forename: Rafael L
authors.initials: RL
authors.lastname: Portella
authors.forename: Jose E
authors.initials: JE
authors.lastname: Tanus-Santos
mesh_terms: D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D005260:Female; D052247:Nitric Oxide Synthase Type II / Q000037:antagonists & inhibitors*; D011225:Pre-Eclampsia / Q000188:drug therapy* / Q000201:enzymology; D011247:Pregnancy; D051381:Rats
chemical_list: D000959:Antihypertensive Agents; D052247:Nitric Oxide Synthase Type II
keywords: Pre-eclampsia; RUPP; inducible nitric oxide synthase; nitrotyrosine; oxidative stress; reduced uteroplacental perfusion pressure
references.citation: J Hum Hypertens. 2012 Sep;26(9):547-52
references.pmid: 21716319
references.citation: Hypertension. 2005 Dec;46(6):1243-9
references.pmid: 16230510
references.citation: Br J Pharmacol. 2000 Oct;131(3):631-7
references.pmid: 11015317
references.citation: Hypertension. 2011 May;57(5):941-8
references.pmid: 21383306
references.citation: Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H541-50
references.pmid: 18055511
references.citation: Gut. 2006 Apr;55(4):542-6
references.pmid: 16299035
references.citation: Hypertension. 2004 Apr;43(4):832-6
references.pmid: 14769812
references.citation: Physiol Rev. 2007 Jan;87(1):315-424
references.pmid: 17237348
references.citation: J Biol Chem. 1997 Feb 21;272(8):4959-63
references.pmid: 9030556
references.citation: Curr Opin Nephrol Hypertens. 2009 Mar;18(2):122-7
references.pmid: 19430333
references.citation: Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2080-4
references.pmid: 17644567
references.citation: Hypertension. 2011 Nov;58(5):935-42
references.pmid: 21931069
references.citation: Acta Pharmacol Sin. 2010 Oct;31(10):1324-8
references.pmid: 20835265
references.citation: Nat Clin Pract Nephrol. 2005 Dec;1(2):98-114; quiz 120
references.pmid: 16932375
references.citation: Am J Hypertens. 2008 Oct;21(10):1152-6
references.pmid: 18670418
references.citation: Br J Pharmacol. 2010 May;160(1):77-87
references.pmid: 20331602
references.citation: J Obstet Gynaecol Res. 2010 Apr;36(2):239-47
references.pmid: 20492372
references.citation: Expert Rev Mol Med. 2006 Jan 26;8(3):1-20
references.pmid: 16438753
references.citation: ScientificWorldJournal. 2012;2012:243476
references.pmid: 22593668
references.citation: Gend Med. 2008;5 Suppl A:S133-8
references.pmid: 18395679
references.citation: Hypertension. 2008 Aug;52(2):402-7
references.pmid: 18574068
references.citation: J Pharmacol Exp Ther. 2008 Jan;324(1):368-75
references.pmid: 17925480
references.citation: Hypertension. 2005 Oct;46(4):1022-5
references.pmid: 16144982
references.citation: Hypertension. 2002 Feb;39(2 Pt 2):586-90
references.pmid: 11882613
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2010 Oct;382(4):293-301
references.pmid: 20694791
references.citation: Am J Obstet Gynecol. 1999 Feb;180(2 Pt 1):499-506
references.pmid: 9988826
references.citation: Methods Mol Med. 2006;122:383-92
references.pmid: 16511995
references.citation: Science. 2005 Jun 10;308(5728):1592-4
references.pmid: 15947178
references.citation: Mol Interv. 2011 Feb;11(1):27-35
references.pmid: 21441119
references.citation: Free Radic Biol Med. 2009 May 1;46(9):1298-307
references.pmid: 19248829
references.citation: Diabetes Care. 2008 Feb;31 Suppl 2:S170-80
references.pmid: 18227481
references.citation: Int J Exp Pathol. 2006 Dec;87(6):425-36
references.pmid: 17222210
references.citation: J Appl Physiol (1985). 2008 Oct;105(4):1076-82
references.pmid: 18635878
references.citation: Hypertension. 2001 Apr;37(4):1191-5
references.pmid: 11304523
references.citation: Am J Obstet Gynecol. 2011 Jun;204(6):503.e1-12
references.pmid: 21529757
references.citation: Lancet. 2010 Aug 21;376(9741):631-44
references.pmid: 20598363
references.citation: Circ Res. 2007 Sep 28;101(7):692-702
references.pmid: 17704205
references.citation: Clin Sci (Lond). 2006 Oct;111(4):275-80
references.pmid: 16803456
references.citation: Obstet Gynecol. 1994 Dec;84(6):937-40
references.pmid: 7526306
references.citation: Lancet. 2005 Feb 26-Mar 4;365(9461):785-99
references.pmid: 15733721
references.citation: Prog Cardiovasc Dis. 1995 Sep-Oct;38(2):87-104
references.pmid: 7568906
references.citation: Biol Chem. 2003 Oct-Nov;384(10-11):1343-64
references.pmid: 14669979
references.citation: Curr Drug Targets. 2013 Mar;14(3):325-34
references.pmid: 23316964